Cargando…
Novel Antibiotics for Multidrug-Resistant Gram-Positive Microorganisms
Increasing multidrug-resistance to Gram-positive pathogens, particularly to staphylococci, enterococci and streptococci, is a major problem, resulting in significant morbidity, mortality and healthcare costs. In recent years, only a small number of novel antibiotics effective against Gram-positive b...
Autores principales: | Koulenti, Despoina, Xu, Elena, Yin Sum Mok, Isaac, Song, Andrew, Karageorgopoulos, Drosos E., Armaganidis, Apostolos, Lipman, Jeffrey, Tsiodras, Sotirios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723731/ https://www.ncbi.nlm.nih.gov/pubmed/31426596 http://dx.doi.org/10.3390/microorganisms7080270 |
Ejemplares similares
-
Lefamulin. Comment on: “Novel Antibiotics for Multidrug-Resistant Gram-Positive Microorganisms. Microorganisms, 2019, 7, 270”
por: Koulenti, Despoina, et al.
Publicado: (2019) -
Emerging Treatment Options for Infections by Multidrug-Resistant Gram-Positive Microorganisms
por: Koulenti, Despoina, et al.
Publicado: (2020) -
The Role of Minocycline in the Treatment of Nosocomial Infections Caused by Multidrug, Extensively Drug and Pandrug Resistant Acinetobacter baumannii: A Systematic Review of Clinical Evidence
por: Fragkou, Paraskevi C., et al.
Publicado: (2019) -
Editorial for Special Issue “Multidrug-Resistant Pathogens”
por: Koulenti, Despoina, et al.
Publicado: (2020) -
Ventilator-Associated Tracheobronchitis: To Treat or Not to Treat?
por: Koulenti, Despoina, et al.
Publicado: (2020)